VANGUARD 7, liofilizat i suspenzija za suspenziju za injekciju, za pse
VANGUARD 7, liofilizat i suspenzija za suspenziju za injekciju, za pse
Authorised
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
- Canine parvovirus, strain NL-35-D, Live
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine distemper virus, strain N-CDV, Live
Product identification
Medicine name:
VANGUARD 7, liofilizat i suspenzija za suspenziju za injekciju, za pse
Active substance:
- Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated
- Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated
- Canine parvovirus, strain NL-35-D, Live
- Canine parainfluenza virus, strain NL-CPI-5, Live
- Canine adenovirus 2, strain Manhattan, Live
- Canine distemper virus, strain N-CDV, Live
Target species:
-
Dog
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Icterohaemorrhagiae, strain NADL 11403, Inactivated463.00relative unit(s)1.00Dose
-
Leptospira interrogans, serogroup Canicola, serovar Canicola, strain C51, Inactivated420.00relative unit(s)1.00Dose
-
Canine parvovirus, strain NL-35-D, Live10000000.00cell culture infective dose 501.00Dose
-
Canine parainfluenza virus, strain NL-CPI-5, Live1000000.00cell culture infective dose 501.00Dose
-
Canine adenovirus 2, strain Manhattan, Live1000.00cell culture infective dose 501.00Dose
-
Canine distemper virus, strain N-CDV, Live1000.00cell culture infective dose 501.00Dose
Pharmaceutical form:
-
Lyophilisate and suspension for suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AI02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Package description:
- Available only in Croatian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Zoetis Belgium
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/13-01/320
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 11/05/2023
How useful was this page?: